1310 - Evaluation of two novel Cyclin Dependent Kinase 9 inhibitors for the treatment of Myeloid Cell Leukaemia 1 (MCL1) high Chronic Lymphocytic Leukaemia

Primary Author / Presenter(s)

EH

Eun Young Han, MD

University Hospitals Sussex NHS Foundation Trust
Brighton, England, United Kingdom
IA

Iona Ashworth, MD

Brighton & Sussex Medical School, England, United Kingdom
EK

Emma M. Kennedy, PhD

Post-Doctoral Research Scientist
Brighton and Sussex Medical School
Brighton, England, United Kingdom
AV

Aimilia Vareli, MRes

Brighton and Sussex Medical School
Brighton, England, United Kingdom
JJ

John Jones, MD, PhD

East Sussex Healthcare NHS Trust
Eastbourne, England, United Kingdom
EL

Eleni Ladikou, MD, PhD

East Sussex Healthcare NHS Trust
Eastbourne, England, United Kingdom
RJ

Rosalynd Johnston, MD

University Hospitals Sussex NHS Foundation Trust
Brighton, England, United Kingdom
FS

Fabio Simoes, PhD

Brighton and Sussex Medical School
Brighton, England, United Kingdom
SM

Simon Mitchell, PhD

Brighton and Sussex Medical School
Brighton, England, United Kingdom
SW

Shudong Wang, PhD

University of South Australia
Adelaide, South Australia, Australia
CP

Chris Pepper, PhD

Brighton and Sussex Medical School
Brighton, England, United Kingdom
Andrea Pepper, PhD

Brighton and Sussex Medical School
University of Sussex
Brighton, England, United Kingdom